BMJ Open Diabetes Research & Care (Apr 2020)

Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

  • Jan Maurik van den Heuvel,
  • Niloufar Farzan,
  • Anke-Hilse Maitland-van der Zee,
  • Fariba Ahmadizar

DOI
https://doi.org/10.1136/bmjdrc-2019-000705corr1
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

No abstracts available.